Shaare Zedek Medical Center — Jerusalem, Jerusalem

Public research footprint of Shaare Zedek Medical Center, compiled from the ClinicalTrials.gov public registry.

676

Registered studies

260

Active

125

Recruiting now

266

Completed

Stopped or withdrawn

Most-studied conditions

Endometrial Cancer · Crohn Disease · Ulcerative Colitis · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT07286149 — A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer… (Recruiting)
NCT07483099 — A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone)… (Recruiting)
NCT06937099 — Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Shaare Zedek Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.